DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative Trial-Reference-Cited by-同舟云学术

DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative Trial

Published:2022-01 Issue:1 Volume:8 Page:e08666
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Hugh Judith C.^ORCID,Haddon Lacey S.J.,Githaka John Maringa,Bigras Gilbert^ORCID,Hu Xiuying^ORCID,Madden Brittney,Hanson John,Gabos Zsolt^ORCID,Giannakopoulos Nadia V.^ORCID,Huang Fleur^ORCID,Hitt Mary M.^ORCID,McManus Kirk J.^ORCID,Olson David,Dabbs Kelly,Mackey John R.

Funder

Alberta Cancer Foundation

Canadian Cancer Society Research Institute

University of Alberta Faculty of Medicine and Dentistry

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference42 articles.

1. Systemic therapy for estrogen receptor-positive HER2-negative breast cancer;Burstein;N. Engl. J. Med.,2020

2. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update;Burstein;J. Clin. Oncol.,2014

3. A correlative morphological-study of human-breast and endometrium in the menstrual-Cycle;Longacre;Am. J. Surg. Pathol.,1986

4. Morphological changes in breast tissue with menstrual cycle;Ramakrishnan;Mod. Pathol.,2002

5. Breast cancer incidence in black and white women stratified by estrogen and progesterone receptor statuses;Gleason;PLoS One,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DREAM On, DREAM Off: A Review of the Estrogen Paradox in Luminal A Breast Cancers;Biomedicines;2024-06-12

2. Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches;Cancers;2023-07-17